MCID: DNG003
MIFTS: 57

Dengue Disease malady

Rare diseases, Infectious diseases categories

Aliases & Classifications for Dengue Disease

About this section
Sources:
32LifeMap Discovery®, 10Disease Ontology, 12DISEASES, 45NIH Rare Diseases, 65UMLS, 51Orphanet, 2CDC, 47Novoseek, 35MedlinePlus, 36MeSH, 29ICD9CM, 59SNOMED-CT, 42NCIt, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet, 27ICD10
See all sources

Aliases & Descriptions for Dengue Disease:

Name: Dengue Disease 32 10 12
Dengue Fever 10 45 51 2 65
Dengue 47 35 36
Dengue Shock Syndrome 45 65
Df 51 2
Philippine Hemorrhagic Fever 45
Singapore Hemorrhagic Fever 45
 
Dengue Hemorrhagic Fever 45
Dengue Virus Infection 51
Thai Hemorrhagic Fever 45
Hemorrhagic Dengue 45
Breakbone Fever 10
Classic Dengue 10
Severe Dengue 65


Classifications:



Characteristics (Orphanet epidemiological data):

51
dengue fever:
Prevalence: >1/1000 (Worldwide); Age of onset: All ages; Age of death: any age


External Ids:

Disease Ontology10 DOID:12205
ICD9CM29 061
MeSH36 D003715
NCIt42 C34528
Orphanet51 99828
ICD10 via Orphanet28 A90, A91
MESH via Orphanet37 D003715
UMLS via Orphanet66 C0011311
ICD1027 A90

Summaries for Dengue Disease

About this section
MedlinePlus:35 Dengue is an infection caused by a virus. you can get it if an infected mosquito bites you. dengue does not spread from person to person. it is common in warm, wet areas of the world. outbreaks occur in the rainy season. dengue is rare in the united states. symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. in some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from your nose, gums, or under your skin. it can also become dengue shock syndrome, which causes massive bleeding and shock. these forms of dengue are life-threatening. there is no specific treatment. most people with dengue recover within 2 weeks. until then, drinking lots of fluids, resting and taking non-aspirin fever-reducing medicines might help. people with the more severe forms of dengue usually need to go to the hospital and get fluids. to lower your risk when traveling in dengue-prone countries wear insect repellent with deet wear clothes that cover your arms, legs and feet close unscreened doors and windows nih: national institute of allergy and infectious diseases

MalaCards based summary: Dengue Disease, also known as dengue fever, is related to thrombocytopenia and systemic lupus erythematosus, and has symptoms including facial pain/cephalalgia/migraine, fever/chilling and cutaneous rash. An important gene associated with Dengue Disease is CD209 (CD209 Molecule), and among its related pathways are LDL Oxidation in Atherogenesis and Development_Thrombopoetin signaling via JAK-STAT pathway. Affiliated tissues include eye, bone and skin, and related mouse phenotypes are hematopoietic system and immune system.

Disease Ontology:10 A viral infectious disease that results in infection, has material basis in dengue virus [ncbitaxon:12637] with four serotypes (dengue virus 1, 2, 3 and 4), which are transmitted by aedes mosquito bite. the infection has symptom fever, has symptom severe headache, has symptom severe pain behind the eyes, has symptom joint pain, has symptom muscle and bone pain, has symptom rash, and has symptom mild bleeding.

Related Diseases for Dengue Disease

About this section

Diseases related to Dengue Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 380)
idRelated DiseaseScoreTop Affiliating Genes
1thrombocytopenia30.3ICAM1, VCAM1
2systemic lupus erythematosus30.3CCL5, CD40LG, ICAM1, MBL2, VCAM1
3hypersensitivity reaction type iv disease30.2CD40LG, ICAM1
4vein disease30.1CD40LG, ICAM1, VCAM1
5leprosy30.1CD209, CD40LG, MRC1
6viral meningitis30.1CCL5, CD209, CD40LG
7allergic rhinitis30.0CCL5, ICAM1, VCAM1
8dengue hemorrhagic fever27.5CCL5, CD209, CD40LG, HCFC1, ICAM1, IVNS1ABP
9yellow fever10.7
10hepatitis10.6
11pancreatitis10.6
12encephalopathy10.6
13human immunodeficiency virus infectious disease10.5
14hemophagocytic lymphohistiocytosis10.5
15west nile virus10.5
16pituitary apoplexy10.5
17acute pancreatitis10.5
18myocarditis10.5
19adult syndrome10.4
20nutritional deficiency disease10.4
21ipex syndrome10.4
22chikungunya10.4
23malaria10.4
24acalculous cholecystitis10.4
25japanese encephalitis10.4
26atrial fibrillation10.4
27cholecystitis10.4
28compartment syndrome10.4
29encephalitis10.4
30hepadnavirus infection10.4
31liver disease10.3
32sexual disorder10.3
33leptospirosis10.3
34typhus10.3
35aspergillosis10.3
36lymphoma aidsrelated10.3ICAM1, VCAM1
37immunotactoid glomerulopathy10.3CD40LG, MBL2
38inflammatory liposarcoma10.3ICAM1, VCAM1
39maxillary sinus inverted papilloma10.3ICAM1, VCAM1
40breast intracanalicular fibroadenoma10.3CD209, CD40LG
41influenza10.3
42inappropriate adh syndrome10.3ICAM1, VCAM1
43breast angiosarcoma10.3ICAM1, VCAM1
44congenital cataract - progressive muscular hypotonia - hearing loss - developmental delay10.3ICAM1, VCAM1
45pemphigus10.3CD40LG, ICAM1
46immunodeficiency 2410.3
47cd4 deficiency10.3
48mills syndrome10.3
49cd40 ligand deficiency10.3CD40LG, MBL2
50laryngeal tuberculosis10.3CD40LG, THPO

Graphical network of the top 20 diseases related to Dengue Disease:



Diseases related to dengue disease

Symptoms for Dengue Disease

About this section

Symptoms:

 51 10 (show all 30)
  • facial pain/cephalalgia/migraine
  • fever/chilling
  • cutaneous rash
  • pruritus/itching
  • acute abdominal pain/colic
  • articular/joint pain/arthralgia
  • purpura/petichiae
  • ecchymoses
  • ascitis
  • nausea/vomiting/regurgitation/merycism/hyperemesis
  • acute diarrhea
  • gastrointestinal bleeding/hemorrhage/hematemesis/melena/rectorrhagia
  • hepatomegaly/liver enlargement (excluding storage disease)
  • collapse/sudden death/cardiac arrest/cardiorespiratory arrest
  • hypotension
  • obnubilation/coma/lethargia/desorientation
  • leukopenia/hypoleukocytosis
  • thrombocytopenia/thrombopenia
  • epistaxis/nose bleeding
  • gingivorrhagia/gingival bleeding
  • intracranial/cerebral/meningeal hemorrhage
  • hypoproteinemia
  • early death/lethality
  • fever
  • severe headache
  • severe pain behind the eyes
  • joint pain
  • muscle
  • rash
  • mild bleeding

Drugs & Therapeutics for Dengue Disease

About this section

Drugs for Dengue Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
IvermectinapprovedPhase 2, Phase 34570288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
 
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
Sklice
Soolantra
Stromectol
2Insect RepellentsPhase 32
3
NeomycinapprovedPhase 1, Phase 2371404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
Framygen
 
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neo-fradin
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Theraplusplus Plus
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
4
RibavirinapprovedPhase 291436791-04-537542
Synonyms:
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide
36791-04-5
437710-49-1
66510-90-5
AA-504/07617051
AB00430481
AC1L1XXZ
AC1Q1IDC
AC1Q4ZGS
AKOS001715163
BB_NC-0567
BPBio1_001195
BRN 0892462
BSPBio_001085
BSPBio_003352
C-Virin
CHEMBL1643
CID37542
Copegus
Copegus (TN)
Cotronak
D00423
DB00811
DRG-0028
DivK1c_000782
Drug: Ribavirin
EU-0101063
FT-0082885
HMS2090L15
HMS2094O09
HMS502H04
HSDB 6513
ICN-1229
IDI1_000782
Ibavyr
KBio1_000782
KBio2_002328
KBio2_004896
KBio2_007464
KBio3_002854
KBioGR_001804
KBioSS_002331
KS-1104
LS-1241
Lopac0_001063
MLS000028486
MLS002222317
Moderiba
MolPort-002-507-104
MolPort-002-885-856
NCGC00090726-01
NCGC00090726-03
NCGC00090726-04
NCGC00090726-05
NCGC00090726-06
NCGC00090726-07
NINDS_000782
 
NSC 163039
NSC163039
Prestwick3_000993
R 9644
R-964
R9644_SIGMA
RBV
RG-964
RIBAV
RTC
RTCA
RTP
Ravanex
Rebetol
Rebetol (TN)
Rebetron
Rebretron
Ribacine
Ribamide
Ribamidil
Ribamidyl
Ribasphere
Ribasphere (TN)
Ribasphere Ribapak
Ribav
Ribavirin
Ribavirin (JAN/USP/INN)
Ribavirin Capsules
Ribavirin Triphosphate
Ribavirin [USAN:INN]
Ribavirin-TP
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirinum
Ribavirinum [INN-Latin]
Ribovirin
Ro 20-9963/000
Ro-20-9963
S2504_Selleck
SCH 18908
SMP1_000261
SMR000058315
SPECTRUM1503938
SR-01000076112-3
Spectrum3_001876
Spectrum4_001252
Spectrum5_002075
Spectrum_001826
Tribavirin
UNII-49717AWG6K
Varazid
Vilona
Viramid
Viramide
Virazid
Virazide
Virazole
Virazole (Ribavirin) Inhalation Solution
Virazole (TN)
Virazole 5'-triphosphate
ZINC01035331
ribavirin
5
HydrocortisoneapprovedPhase 255050-23-75754, 657311
Synonyms:
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
1 Hydrocortisone maximum strength
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11β-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
999 Itch Relieving
A-hydrocort
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Advanced Hydrocortisone
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti Itch
Anti Itch maximum strength
Anti Itch maximum strength plus
Anti-inflammatory hormone
Anti-itch
Anti-itch Scalp Relief Maximum Strength
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Apres Peel Soothing Balm
Aquacort
Aquanil HC
Atopalm Maximum Strength Anti-itch
Atopalm Moisturizing Hydrocortisone
Aveeno Hydrocortisone Anti Itch
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
Bioelements Immediate Comfort Hydrocortisone
Budpak Anti-itch
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Caldecort
Care One Hydrocortisone maximum strength
Cetacort
Chronocort
Cicatricure Ultra Moisturizing
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortaid 12-hour Advanced Anti-Itch
Cortaid Intensive Therapy Cooling
Cortaid Maximum Strength
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisone
Cortisone Cream Intensive Healing
Cortisone Maximum Strength
Cortisone maximum strength
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortizone 10
Cortizone 10 Cooling Cream Anti-itch
Cortizone 10 Cooling Relief
Cortizone 10 Easy Relief
Cortizone 10 Hydratensive Healing Anti Itch
Cortizone 10 Hydratensive Soothing Anti Itch
Cortizone 10 Intensive Healing
Cortizone 10 Intensive Healing Feminine Itch Relief
Cortizone 10 Intensive Healing For Eczema
Cortizone 10 Plus
Cortizone 10 Poison Ivy Relief Pads
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cvs Anti-itch Hydrocortisone
Cvs Cools Itch Fast
Cvs Cortisone
Cvs Pharmacy Anti-itch
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermacort Anti-Itch
Dermaquest Skin Therapy Post-skin Resurfacing Balm
Dermarest Eczema Medicated
Dermaspray
Dermil
Dermocortal
Dermolate
Dg Health Hydrocortisone
Dg Health Hydrocortisone Cream Maximum Strength
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Dr. Sheffield Hydrocortisone Anti Itch
Drotic
Duane Reade
Duane Reade hydrocortisone
Duane Reade hydrocortisone plus 12 moisturizers
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Equaline Anti Itch
Equaline Anti Itch maximum strength
Equate Hydrocortisone
Esiderm H
Evacort
Family Care Hydrocortisone
Family Wellness
Family Wellness Hydrocortisone
Family Wellness Maximum Strength Hydrocortisone
Ficortril
Fiocortril
Fixmyskin Healing Balm Fragrance-free
Fixmyskin Healing Balm Unflavored
Fixmyskin Healing Balm Vanilla Flavor
Fixmyskin Healing Balm Vanilla Fragrance
Flexicort
Foille Insetti
Formu Care Anti Itch maximum strength
Fulton Street Market Anti Itch
Genacort
Genacort (lotion)
Genuine Hydrocortisone
Glycort
Good Neighbor Pharmacy Anti Itch
Good Neighbor Pharmacy Hydrocortisone
Good Neighbor Pharmacy Hydrocortisone Plus 12 Moisturizers
Good Sense Anti Itch
Gyno-Cortisone
H 4001
H-Cort
H-releve Anti-itch
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Healerz For Itches
Health Mart Pharmacy Hydrocortisone Maximum Strength Plus 12 Moisturizers
Healthy Accents Cortisone maximum strength
Heb Cort
Heb-Cort
 
Hem-easy Relief Herbal Anti-itch Maximum Itch Relief
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro Skin
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone 1 plus 10
Hydrocortisone Acetate
Hydrocortisone Anti-itch Plus
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone D
Hydrocortisone HC
Hydrocortisone Intensive Healing Formula
Hydrocortisone Maximum Strength
Hydrocortisone Maximum Strength Plus 12 Moisturizers
Hydrocortisone Plus
Hydrocortisone Plus 12 Moisturizers
Hydrocortisone Probutate
Hydrocortisone Regular Strength
Hydrocortisone Sodium Phosphate
Hydrocortisone Ultra Strength
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone anti itch
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone maximum strength
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Intensive Healing Anti Itch
Kaiser Permanente Hydrocortisone
Kendall'S compound F
Kendall's compound F
Kera Hc Hydrocortisone
Kirkland Signature Hydrocortisone Plus maximum strength
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Leader Hydrocortisone
Locoid
Loesch Anti-Itch Therapy
Lopac0_000594
Lubricort
Lucky Supersoft MAXIMUM STRENGTH
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Makesense MAXIMUM STRENGTH
Maximum Strength Cortizone 10 Quick Shot 360 Continuous
Maximum Strength Hydrocortisone
Maximum-h
Medicort
Medpride
Meijer Anti Itch
Meijer Anti Itch Cream Plus
Meijer Hydrocortisone
Meijer Hydrocortisone Plus 12 Moisturizers
Members Mark Hydrocortisone
Meusicort
Mildison
Milliderm
MolPort-001-794-637
Monistat Complete Care Instant Itch Relief
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Natureplex Hydrocortisone Hydro
Neo-Cort-Dome
Neo-Cortef
Neosporin Eczema Essentials Anti Itch
Neosporin-H Ear
Nogenic HC
Nu-derm Tolereen Anti-pruritic
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pandel
Pediaderm Hc
Pediotic Suspension
Penecort
Permicort
Piyanping Antiitch
Polcort H
Premier Value Hydrocortisone
Premier Value Hydrocortisone Plus 12 Moisturizers
Preparation H Hydrocortisone
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proactiv Solution Anti-itch Scalp
Procto-pak
Proctocort
Proctocream HC
Proctofoam
Proctosol-hc
Proctozone HC
Procure
Protocort
Publix Hydro
Publix hydro plus
Quadrydern
Quality Choice Hydrocortisone
Quality Choice Hydrocortisone Maximum Strength
Quality Choice Maximum Strength Anti Itch
Racet
Rectasol-HC
Rectoid
Refuge Hc
Reichstein'S substance M
Reichstein's substance M
Remederm HC
Rexall Anti Itch maximum strength relief
Rexall Hydrocortisone 1
Rexall Hydrocortisone plus moisturizers
Rite Aid anti-itch
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Safeway Hydrocortisone Plus 12 Moisturizers
Sanatison
Scalp-Cort
Scalpicin Anti-Itch Maximum Strength
Scalpicin Capilar
Scalpicin Maximum Strength
Scalpicin Scalp Itch Medication Maximum Strength
Schericur
Scheroson F
Shopko Hydrocortisone
Shopko Hydrocortisone Intensive Healing Formula
Shopko Hydrocortisone Maximum Strength
Shopko Hydrocortisone Plus 12 Moisturizers Maximum Strength
Shopko Maximum Strength
Shoprite Hydrocortisone
Sigmacort
Signef
Smart Sense Anti Itch
Smart Sense Anti Itch maximum strength
Smart Sense Hydrocortisone
Solu-cortef
Soothe Rodan Fields
Stie-cort
Stiefcorcil
Sunmark Hydrocortisone
Sunmark Hydrocortisone Plus 12 Moisturizers
Synacort
Systral Hydrocort
Tarcortin
Tecnu Corticool
Texacort
Texacort lotion 25
Thera Plus
Timocort
Topcare Hydrocortisone
Topcare Hydrocortisone Intensive Healing Formula
Topcare Hydrocortisone Plus 12 Moisturizers
Topicort
Transderma H
Traumaide
Truelipids Anti-itch Barrier
U-cort
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Walgreens Hydrocortisone Plus 12 Moisturizers
Westcort
Western Family HydroCortisone
Western Family HydroCortisone Plus 12 Moisturizers
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
6
chloroquineapprovedPhase 1, Phase 213754-05-72719
Synonyms:
( -)-Chloroquine
(+)-Chloroquine
(-)-Chloroquine
(R)-(-)-Chloroquine
3377 RP opalate
3545-67-3
50-63-5
54-05-7
56598-66-4
58175-86-3
58175-87-4
7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline
7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline
AB00053436
AC1L1EB8
AC1Q2ZA7
AC1Q2ZA8
Amokin
Aralen
Aralen HCl
Arechin
Arechine
Arequin
Arolen
Arthrochin
Artrichin
Avlochlor
Avloclor
BPBio1_000655
BRD-A91699651-065-01-1
BRN 0482809
BSPBio_000595
BSPBio_002001
Bemaco
Bemaphate
Bemasulph
Benaquin
Bipiquin
C07625
C18H26ClN3
CCRIS 3439
CHEBI:3638
CHEMBL76
CID2719
CQ
CU-01000012392-2
Capquin
Chemochin
Chingamin
Chloraquine
Chlorochin
Chlorochine
Chlorochinum
Chloroin
Chloroquin
Chloroquina
Chloroquine
Chloroquine (USP/INN)
Chloroquine (VAN)
Chloroquine Bis-Phosphoric Acid
Chloroquine Phosphate
Chloroquine [USAN:INN:BAN]
Chloroquine phosphate
Chloroquinium
Chloroquinum
Chloroquinum [INN-Latin]
Chlorquin
Cidanchin
Clorochina
Clorochina [DCIT]
Cloroquina
Cloroquina [INN-Spanish]
Cocartrit
D02366
DB00608
Dawaquin
Delagil
Dichinalex
DivK1c_000404
EINECS 200-191-2
Elestol
Gontochin
Gontochin phosphate
HMS2090O03
HSDB 3029
Heliopar
Hydroxychloroquine Sulfate
IDI1_000404
Imagon
Ipsen 225
 
Iroquine
KBio1_000404
KBio2_000592
KBio2_003160
KBio2_005728
KBio3_001221
KBioGR_000778
KBioSS_000592
Khingamin
Klorokin
LS-141726
Lapaquin
Lopac0_000296
Malaquin
Malaquin (*Diphosphate*)
Malaren
Malarex
Mesylith
Miniquine
MolMap_000009
MolPort-001-783-623
N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine
N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine
NCGC00015256-04
NCGC00162120-01
NCI60_000894
NINDS_000404
NSC 187208
NSC14050
NSC187208
Neochin
Nivachine
Nivaquine
Nivaquine B
Nivaquine b
Pfizerquine
Plaquenil
Prestwick0_000548
Prestwick1_000548
Prestwick2_000548
Prestwick3_000548
Quinachlor
Quinagamin
Quinagamine
Quinercyl
Quingamine
Quinilon
Quinoscan
RP 3377
RP-3377
Resochen
Resochin
Resoquina
Resoquine
Reumachlor
Reumaquin
Rivoquine
Ro 01-6014/N2
Ronaquine
Roquine
SMP2_000034
SN 6718
SN-7618
SPBio_000174
SPBio_002516
ST 21
ST 21 (pharmaceutical)
Sanoquin
Silbesan
Siragan
Solprina
Sopaquin
Spectrum2_000127
Spectrum3_000341
Spectrum4_000279
Spectrum5_000707
Spectrum_000132
Tanakan
Tanakene
Tresochin
Trochin
UNII-886U3H6UFF
W 7618
WIN 244
WLN: T66 BNJ EMY1&3N2&2 IG
chloroquine
nchembio.215-comp4
nchembio.368-comp8
nchembio.87-comp17
{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
7CoagulantsPhase 2983
8AlbunexPhase 1, Phase 2145
9Hydrocortisone-17-butyratePhase 2550
10Cortisol succinatePhase 2550
11Hydrocortisone acetatePhase 2550
12Hydrocortisone 17-butyrate 21-propionatePhase 2550
13Chloroquine diphosphatePhase 1, Phase 213750-63-5
14AnthelminticsPhase 1, Phase 2363
15
Aluminum hydroxideapprovedPhase 1169
Synonyms:
Al(OH)3
Aluminiumhydroxid
 
Aluminum Hydroxide
Aluminum hydroxide
Dermadrox
16Aluminum sulfatePhase 177
17PapayaNutraceuticalPhase 113
18
Permethrinapproved, investigational2552645-53-140326
Synonyms:
(+)-CIS-PERMETHRIN
(+)-trans-Permethrin
(+-)-cis-Fmc 33297
(+-)-cis-Permethrin
(+-)-trans-Permethrin
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
1RS,cis-Permethrin
1RS-trans-Permethrin
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-Phenoxybenzyle (1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate
3-phenoxybenzyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
442748_SUPELCO
45614_FLUKA
45614_RIEDEL
45893_FLUKA
45893_RIEDEL
47956_SUPELCO
52341-32-9
52341-33-0
52645-53-1
AC1L23IC
AC1Q3FFG
AI3-29296
Acticin Cream
Ambush
BRN 4153590
C21H20Cl2O3
CHEBI:34911
CHEMBL1525
CID40326
DB04930
Elimite
Elimite Cream
Equaline Lice Treatment
FMC 35171
 
Good Neighbor Pharmacy Lice Treatment
Good Sense Lice Treatment
LS-58636
LS-58640
Leader Lice Treatment
Lice Treatment
MLS001332525
MLS001332526
MolPort-003-933-021
NCGC00159390-00
NCGC00159390-02
NCGC00159390-04
NCGC00159390-05
NCGC00159390-06
NCGC00159390-07
NCGC00159390-08
NCGC00159390-09
NRDC 146
NRDC 148
Nix
Nix Complete Maximum Strength Lice Elimination
Nix Cream Rinse
PS758_SUPELCO
PerFoam
Permethrin
Permethrin (isomers)
Permethrin (isomers) solution
Permethrine,c&t
SMR000778043
ST50975270
Smart Sense Lice Treatment
TL8003462
Topcare Lice Treatment
Transpermethrin
Transpermethrin [ISO]
[3-(phenyloxy)phenyl]methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
trans-(+-)-Permethrin
19Immunoglobulins, Intravenous203
20Rho(D) Immune Globulin198

Interventional clinical trials:

(show top 50)    (show all 129)
idNameStatusNCT IDPhase
1Ketotifen as a Treatment for Vascular Leakage During Dengue FeverRecruitingNCT02673840Phase 4
2Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)Not yet recruitingNCT02555072Phase 4
3Study of a Tetravalent Dengue Vaccine in Healthy Adults in AustraliaCompletedNCT01134263Phase 3
4Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedNCT01436396Phase 3
5Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy ToddlersCompletedNCT01411241Phase 3
6Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in MalaysiaCompletedNCT01254422Phase 3
7Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue VaccineRecruitingNCT02406729Phase 3
8Efficacy and Safety of Ivermectin Against Dengue InfectionRecruitingNCT02045069Phase 2, Phase 3
9Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDRRecruitingNCT00938379Phase 3
10Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in AsiaActive, not recruitingNCT01373281Phase 3
11Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin AmericaActive, not recruitingNCT01374516Phase 3
12Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)Active, not recruitingNCT00966628Phase 3
13Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCompletedNCT01488890Phase 2
14A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the PhilippinesCompletedNCT01064141Phase 2
15Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in IndiaCompletedNCT01550289Phase 2
16Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin AmericaCompletedNCT00993447Phase 2
17Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in SingaporeCompletedNCT00880893Phase 2
18Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South AmericaCompletedNCT01187433Phase 2
19A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive InfantsCompletedNCT00322049Phase 1, Phase 2
20Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsCompletedNCT00730288Phase 2
21A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve ChildrenCompletedNCT00384670Phase 1, Phase 2
22Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy SubjectsCompletedNCT00875524Phase 2
23Efficacy and Safety of Dengue Vaccine in Healthy ChildrenCompletedNCT00842530Phase 2
24Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the USCompletedNCT00617344Phase 2
25Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve AdultsCompletedNCT00740155Phase 2
26Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsCompletedNCT00788151Phase 2
27A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive ChildrenCompletedNCT01843621Phase 1, Phase 2
28A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00239577Phase 2
29A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and ChildrenCompletedNCT00468858Phase 2
30Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in AsiaCompletedNCT01218906Phase 2
31A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00350337Phase 2
32A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in ThailandCompletedNCT00370682Phase 2
33Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)CompletedNCT02193087Phase 2
34Celgosivir as a Treatment Against DengueCompletedNCT01619969Phase 1, Phase 2
35Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic FeverCompletedNCT01601613Phase 2
36Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue VaccineRecruitingNCT01943825Phase 2
37Safety and Immunogenicity With Two Different Serotype 2 Potencies of Tetravalent Dengue Vaccine (TDV) in Adults in SingaporeRecruitingNCT02425098Phase 2
38Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US AdultsRecruitingNCT02421367Phase 1, Phase 2
39Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in ThailandRecruitingNCT02332733Phase 2
40Chinese and Western Medicine Treatment of Fever Associated With Bleeding SymptomsRecruitingNCT01973855Phase 2
41Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) VaccineActive, not recruitingNCT01696422Phase 2
42Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy ParticipantsActive, not recruitingNCT02302066Phase 2
43Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 YearsActive, not recruitingNCT01511250Phase 2
44The Effect of Chloroquine in the Treatment of Patients With DengueActive, not recruitingNCT00849602Phase 1, Phase 2
45The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansActive, not recruitingNCT01943305Phase 2
46Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of AgeNot yet recruitingNCT02628444Phase 2
47Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose ScheduleNot yet recruitingNCT02623725Phase 2
48Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, BangladeshNot yet recruitingNCT02678455Phase 2
49Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in SingaporeNot yet recruitingNCT02569827Phase 1, Phase 2
50Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue DiseaseCompletedNCT01502358Phase 1

Search NIH Clinical Center for Dengue Disease


Cochrane evidence based reviews: Dengue

Genetic Tests for Dengue Disease

About this section

Anatomical Context for Dengue Disease

About this section

MalaCards organs/tissues related to Dengue Disease:

33
Eye, Bone, Skin, T cells, Liver, Kidney, Pituitary

Animal Models for Dengue Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Dengue Disease:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.4CCL5, CD40LG, ICAM1, MBL2, MRC1, PIK3C2A
2MP:00053876.9CCL5, CD209, CD40LG, ICAM1, MBL2, MRC1
3MP:00053766.7CD209, CD40LG, ICAM1, IVNS1ABP, MBL2, MRC1

Publications for Dengue Disease

About this section

Articles related to Dengue Disease:

(show top 50)    (show all 74)
idTitleAuthorsYear
1
Antibody-enhanced dengue disease generates a marked CNS inflammatory response in the black-tufted marmoset Callithrix penicillata. (26303046)
2015
2
Biomarkers of severe dengue disease - a review. (26462910)
2015
3
Antibodies against immature virions are not a discriminating factor for dengue disease severity. (25760350)
2015
4
Dengue Disease Risk Mental Models in the City of Dhaka, Bangladesh: Juxtapositions and Gaps Between the Public and Experts. (26387980)
2015
5
Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy. (26220099)
2015
6
Evolution of dengue disease and entomological monitoring in Santa Cruz, Bolivia 2002 - 2008. (25706631)
2015
7
Epidemiological trends of dengue disease in Colombia (2000-2011): a systematic review. (25790245)
2015
8
Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of CearA!, Brazil. (24626308)
2014
9
Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis. (25375162)
2014
10
Dengue disease surveillance: an updated systematic literature review. (24889501)
2014
11
Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence. (24216294)
2014
12
Epidemiology of Dengue Disease in the Philippines (2000-2011): A Systematic Literature Review. (25375119)
2014
13
First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. (24699622)
2014
14
Dengue disease outbreak detection. (25160360)
2014
15
Predictive symptoms and signs of severe dengue disease for patients with dengue fever: a meta-analysis. (25097856)
2014
16
Dengue disease surveillance: improving data for dengue control. (25375232)
2014
17
Epidemiology of dengue disease in malaysia (2000-2012): a systematic literature review. (25375211)
2014
18
Reviewing the literature for epidemiological trends of dengue disease: introduction to a series of seven national systematic literature reviews. (25375830)
2014
19
Dogma in classifying dengue disease. (23926138)
2013
20
Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis. (24386496)
2013
21
The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis. (23476150)
2013
22
Knowledge, attitude, and practice of dengue disease among healthcare professionals in southern Taiwan. (23332425)
2013
23
An optimal control problem arising from a dengue disease transmission model. (23274179)
2013
24
Atypical presentations of dengue disease in the elderly visiting the ED. (23399333)
2013
25
Comment on: "Atypical presentations of dengue disease in the elderly visiting the ED" (24342867)
2013
26
Can non-human primates serve as models for investigating dengue disease pathogenesis? (24130557)
2013
27
Simple Prognostic Criteria can Definitively Identify Patients who Develop Severe Versus Non-Severe Dengue Disease, or Have Other Febrile Illnesses. (22383925)
2012
28
Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity. (20858223)
2011
29
Biosensors and rapid diagnostic tests on the frontier between analytical and clinical chemistry for biomolecular diagnosis of dengue disease: a review. (21241843)
2011
30
Virus role during intraepidemic increase in dengue disease severity. (21254883)
2011
31
Evaluation of the traditional and revised WHO classifications of Dengue disease severity. (22087348)
2011
32
Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. (21502191)
2011
33
Characterization of early host responses in adults with dengue disease. (21810247)
2011
34
Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. (21811645)
2011
35
Changing trends of dengue disease: a brief report from a tertiary care hospital in New Delhi. (21503411)
2011
36
Markers of dengue disease severity. (19802579)
2010
37
Characteristic of dengue disease in Taiwan: 2002-2007. (20348527)
2010
38
A BALB/c mouse model shows that liver involvement in dengue disease is immune-mediated. (20673760)
2010
39
Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. (20153282)
2010
40
Stochastic eco-epidemiological model of dengue disease transmission by Aedes aegypti mosquito. (19861133)
2010
41
Understanding the contribution of cellular immunity to dengue disease pathogenesis. (18837790)
2008
42
Describing the geographic spread of dengue disease by traveling waves. (18590749)
2008
43
Blood group AB is associated with increased risk for severe dengue disease in secondary infections. (17330792)
2007
44
NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. (16412060)
2006
45
Relationship of thrombopoietin and interleukin-11 levels to thrombocytopenia associated with dengue disease. (16759877)
2006
46
Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. (12641411)
2003
47
Immunology and immunopathogenesis of dengue disease. (14689699)
2003
48
Dengue disease spectrum among infants in the 2001 dengue epidemic in Chennai, Tamil Nadu, India. (12904418)
2003
49
A model for dengue disease with variable human population. (10220925)
1999
50
Analysis of a dengue disease transmission model. (9656647)
1998

Variations for Dengue Disease

About this section

Expression for genes affiliated with Dengue Disease

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Dengue Disease patients vs. healthy controls: 32 (show all 93)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1IFI27interferon, alpha-inducible protein 27Blood+4.850.000
2RRM2ribonucleotide reductase M2Blood+4.480.000
3CEP55centrosomal protein 55kDaBlood+4.330.000
4BIRC5baculoviral IAP repeat containing 5Blood+4.300.000
5XISTX inactive specific transcript (non-protein coding)Blood-4.250.009
6CD38CD38 moleculeBlood+4.230.000
7DLGAP5discs, large (Drosophila) homolog-associated protein 5Blood+4.100.000
8BUB1BUB1 mitotic checkpoint serine/threonine kinaseBlood+4.080.000
9IGHMimmunoglobulin heavy constant muBlood+4.040.000
10MCM10minichromosome maintenance 10 replication initiation factorBlood+3.990.000
11SHCBP1SHC SH2-domain binding protein 1Blood+3.970.000
12PBKPDZ binding kinaseBlood+3.970.000
13TYMSthymidylate synthetaseBlood+3.960.000
14PI3peptidase inhibitor 3, skin-derivedBlood-3.930.000
15CDCA2cell division cycle associated 2Blood+3.910.000
16SESN3sestrin 3Blood-3.900.000
17HMMRhyaluronan-mediated motility receptor (RHAMM)Blood+3.830.000
18MKI67marker of proliferation Ki-67Blood+3.830.000
19ZWINTZW10 interacting kinetochore proteinBlood+3.830.000
20DTLdenticleless E3 ubiquitin protein ligase homolog (Drosophila)Blood+3.800.000
21CDK1cyclin-dependent kinase 1Blood+3.780.000
22NCAPGnon-SMC condensin I complex, subunit GBlood+3.760.000
23CDT1chromatin licensing and DNA replication factor 1Blood+3.760.000
24SPC25SPC25, NDC80 kinetochore complex componentBlood+3.750.000
25CDC20cell division cycle 20Blood+3.730.000
26CNTNAP3contactin associated protein-like 3Blood-3.720.000
27TOP2Atopoisomerase (DNA) II alphaBlood+3.710.000
28NOVnephroblastoma overexpressedBlood-3.710.000
29EIF1AYeukaryotic translation initiation factor 1A, Y-linkedBlood+3.690.015
30CCNB2cyclin B2Blood+3.620.000
31CDKN3cyclin-dependent kinase inhibitor 3Blood+3.620.000
32KIAA0101KIAA0101Blood+3.610.000
33KIF2Ckinesin family member 2CBlood+3.600.000
34TK1thymidine kinase 1, solubleBlood+3.590.000
35RPS4Y1ribosomal protein S4, Y-linked 1Blood+3.570.017
36TTKTTK protein kinaseBlood+3.560.000
37CDC6cell division cycle 6Blood+3.560.000
38CAV1caveolin 1, caveolae protein, 22kDaBlood+3.560.000
39CENPAcentromere protein ABlood+3.540.000
40CYAT1immunoglobulin lambda light chain-likeBlood+3.520.000
41ASPMabnormal spindle microtubule assemblyBlood+3.520.000
42OR2W3olfactory receptor, family 2, subfamily W, member 3Blood-3.510.000
43UHRF1ubiquitin-like with PHD and ring finger domains 1Blood+3.500.000
44SELENBP1selenium binding protein 1Blood-3.500.000
45GINS2GINS complex subunit 2 (Psf2 homolog)Blood+3.490.000
46MELKmaternal embryonic leucine zipper kinaseBlood+3.470.000
47BUB1BBUB1 mitotic checkpoint serine/threonine kinase BBlood+3.470.000
48CHEK1checkpoint kinase 1Blood+3.460.000
49CCNB1cyclin B1Blood+3.450.000
50KIF11kinesin family member 11Blood+3.420.000
51E2F8E2F transcription factor 8Blood+3.410.000
52CCNA2cyclin A2Blood+3.400.000
53KCTD14potassium channel tetramerization domain containing 14Blood+3.400.000
54IGLimmunoglobulin lambda locusBlood+3.370.000
55IGLJ3immunoglobulin lambda joining 3Blood+3.350.000
56CDCA5cell division cycle associated 5Blood+3.310.000
57TPX2TPX2, microtubule-associatedBlood+3.310.000
58KIF20Akinesin family member 20ABlood+3.300.000
59E2F7E2F transcription factor 7Blood+3.280.000
60ANLNanillin actin binding proteinBlood+3.280.000
61KDM5Dlysine (K)-specific demethylase 5DBlood+3.280.017
62JAZF1JAZF zinc finger 1Blood-3.270.000
63HJURPHolliday junction recognition proteinBlood+3.250.000
64IGKV3-20immunoglobulin kappa variable 3-20Blood+3.240.000
65KIF4Akinesin family member 4ABlood+3.220.000
66KIF15kinesin family member 15Blood+3.200.000
67CNTNAP3Bcontactin associated protein-like 3BBlood-3.190.000
68TNFRSF17tumor necrosis factor receptor superfamily, member 17Blood+3.190.000
69AURKBaurora kinase BBlood+3.180.000
70TRIP13thyroid hormone receptor interactor 13Blood+3.180.000
71CCND2cyclin D2Blood+3.170.000
72GINS1GINS complex subunit 1 (Psf1 homolog)Blood+3.160.000
73IGLV2-23immunoglobulin lambda variable 2-23Blood+3.150.000
74SLC6A8solute carrier family 6 (neurotransmitter transporter), member 8Blood-3.150.000
75KIF18Bkinesin family member 18BBlood+3.140.000
76OIP5Opa interacting protein 5Blood+3.140.000
77KRT1keratin 1, type IIBlood-3.120.001
78GGHgamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)Blood+3.110.000
79RAD51RAD51 recombinaseBlood+3.100.000
80GLDCglycine dehydrogenase (decarboxylating)Blood+3.100.000
81RAD51AP1RAD51 associated protein 1Blood+3.090.000
82DDX3YDEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linkedBlood+3.090.028
83MBNL3muscleblind-like splicing regulator 3Blood-3.090.000
84IGLV1-44immunoglobulin lambda variable 1-44Blood+3.090.000
85MCM4minichromosome maintenance complex component 4Blood+3.080.000
86IGLV4-60immunoglobulin lambda variable 4-60Blood+3.080.000
87FOXM1forkhead box M1Blood+3.060.000
88ESPL1extra spindle pole bodies like 1, separaseBlood+3.060.000
89SLC4A1solute carrier family 4 (anion exchanger), member 1 (Diego blood group)Blood-3.050.000
90IGLV3-19immunoglobulin lambda variable 3-19Blood+3.040.000
91GTSE1G-2 and S-phase expressed 1Blood+3.040.000
92PDZK1IP1PDZK1 interacting protein 1Blood-3.020.000
93USP18ubiquitin specific peptidase 18Blood+3.000.000

Search GEO for disease gene expression data for Dengue Disease.

Pathways for genes affiliated with Dengue Disease

About this section

GO Terms for genes affiliated with Dengue Disease

About this section

Cellular components related to Dengue Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056158.8CCL5, CD40LG, ICAM1, MBL2, THPO, VCAM1
2cell surfaceGO:00099868.7CD209, ICAM1, MBL2, MRC1, VCAM1

Biological processes related to Dengue Disease according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1membrane to membrane dockingGO:002261410.5ICAM1, VCAM1
2interferon-gamma-mediated signaling pathwayGO:006033310.1ICAM1, PTPN11, VCAM1
3heterophilic cell-cell adhesion via plasma membrane cell adhesion moleculesGO:000715710.0CD209, ICAM1, VCAM1
4regulation of immune responseGO:00507769.7CD40LG, ICAM1, VCAM1
5viral entry into host cellGO:00467189.7CD209, ICAM1, MRC1
6cellular response to lipopolysaccharideGO:00712229.5CCL5, ICAM1, MRC1
7leukocyte cell-cell adhesionGO:00071599.5CCL5, CD209, CD40LG, ICAM1, VCAM1
8positive regulation of ERK1 and ERK2 cascadeGO:00703749.1CCL5, ICAM1, PTPN11, THPO

Molecular functions related to Dengue Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1phosphatidylinositol phospholipase C activityGO:00044359.9CCL5, PLCE1
2virus receptor activityGO:00016189.5CD209, ICAM1, MRC1
3mannose bindingGO:00055379.2CD209, MBL2, MRC1

Sources for Dengue Disease

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet